Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846121 | 12784612 | 1 | I | 20160919 | 20160927 | 20160927 | EXP | PHHY2016US129862 | SANDOZ | ADAY AW, SAAVEDRA AP, LEVY BD, LOSCALZO J. PREVENTION AS PRECIPITANT.. NEW ENGLAND JOURNAL OF MEDICINE (USA). 2016;375 (5):471-75 | 72.00 | YR | M | Y | 0.00000 | 20160927 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846121 | 12784612 | 1 | PS | CEFAZOLIN | CEFAZOLIN | 1 | Unknown | Y | 62831 | ||||||||||
| 127846121 | 12784612 | 2 | C | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | Y | 0 | ||||||||||
| 127846121 | 12784612 | 3 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 127846121 | 12784612 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 127846121 | 12784612 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 127846121 | 12784612 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127846121 | 12784612 | 1 | Product used for unknown indication |
| 127846121 | 12784612 | 2 | Thrombosis prophylaxis |
| 127846121 | 12784612 | 3 | Product used for unknown indication |
| 127846121 | 12784612 | 4 | Product used for unknown indication |
| 127846121 | 12784612 | 5 | Product used for unknown indication |
| 127846121 | 12784612 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127846121 | 12784612 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127846121 | 12784612 | Acute generalised exanthematous pustulosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |